{"id":162366,"date":"2022-05-23T01:48:25","date_gmt":"2022-05-23T05:48:25","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/t2-biosystems-announces-issuance-of-u-s-patent-for-direct-detection-of-lyme-disease\/"},"modified":"2024-08-18T11:44:50","modified_gmt":"2024-08-18T15:44:50","slug":"t2-biosystems-announces-issuance-of-u-s-patent-for-direct-detection-of-lyme-disease","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/t2-biosystems-announces-issuance-of-u-s-patent-for-direct-detection-of-lyme-disease.php","title":{"rendered":"T2 Biosystems Announces Issuance of U.S. Patent for Direct Detection of Lyme Disease"},"content":{"rendered":"<p><![CDATA[LEXINGTON, Mass., May  20, 2022  (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today the U.S. Patent and Trademark Office has issued patent number 11,326,213 (the \u2018213 Patent), \u201cNMR Methods and Systems for the Rapid Detection of Tick-Borne Pathogens\u201d. The \u2018213 Patent covers the T2Lyme\u2122 Panel, which identifies the bacteria that cause Lyme disease directly from a patient\u2019s blood in 3 to 5 hours. The T2Lyme Panel runs on the T2Dx Instrument\u00ae, the same instrument currently used to run the FDA-cleared T2Bacteria\u00ae and T2Candida\u00ae Panels.]]><\/p>\n<p>More here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/05\/20\/2447745\/0\/en\/T2-Biosystems-Announces-Issuance-of-U-S-Patent-for-Direct-Detection-of-Lyme-Disease.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"T2 Biosystems Announces Issuance of U.S. Patent for Direct Detection of Lyme Disease\">T2 Biosystems Announces Issuance of U.S. Patent for Direct Detection of Lyme Disease<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>More here: T2 Biosystems Announces Issuance of U.S. Patent for Direct Detection of Lyme Disease <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/t2-biosystems-announces-issuance-of-u-s-patent-for-direct-detection-of-lyme-disease.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-162366","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/162366"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=162366"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/162366\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=162366"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=162366"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=162366"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}